Nomination of Senior Director, Investor Relations
Theratechnologies is pleased to announce the nomination of Ms. Leah Gibson to the newly created position of Senior Director, Investor Relations. Leah is a seasoned professional with over 17 years of experience in public company investor relations and financial communications. Leah has spent the last seven years at Vertex Pharmaceuticals, a global biotechnology company with sales of over $4 billion in 2019, leading the company’s efforts to attract and retain quality, long-term institutional investors. As Senior Director of Investor Relations, she will be responsible for the development, implementation and management of a strategic plan for investor relations that will maximize Theratechnologies’ visibility on Wall Street and ensure accurate understanding of the company’s business plan among key stakeholders in the investment community. With growing sales and a solid development pipeline, Theratechnologies is well-positioned to create shareholder value in the next few years, and Leah’s experience will be integral to relaying this message to the investment community.
Leah will be based in the Boston area, and report to Philippe Dubuc, Senior Vice President and Chief Financial Officer.